| Q41839457 | A critical role for chloride channel-3 (CIC-3) in smooth muscle cell activation and neointima formation |
| Q57740341 | Acute coronary syndromes, plaque vulnerability,and carotid artery disease |
| Q37707000 | Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets |
| Q33863783 | Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration |
| Q33905535 | An in vivo rat model of artery buckling for studying wall remodeling |
| Q37780199 | Animal, in vitro, and ex vivo models of flow-dependent atherosclerosis: role of oxidative stress |
| Q35738133 | Artery Remodeling Under Axial Twist in Three Days Organ Culture |
| Q36947473 | Associations of MMP1, 3, 9 and TIMP3 genes polymorphism with isolated systolic hypertension in Chinese Han population |
| Q35747927 | Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model |
| Q44180901 | Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS. |
| Q34998689 | Characterization of partial ligation-induced carotid atherosclerosis model using dual-modality molecular imaging in ApoE knock-out mice |
| Q35671324 | Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation |
| Q36033594 | Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease. |
| Q35098005 | Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. |
| Q36777324 | Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis |
| Q44725602 | Differential effects of Rho-kinase inhibition on artery wall mass and remodeling |
| Q51747256 | Dysregulation of RNF213 promotes cerebral hypoperfusion. |
| Q34159834 | Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives |
| Q44474765 | Epigallocatechin-3-gallate binding to MMP-2 inhibits gelatinolytic activity without influencing the attachment to extracellular matrix proteins but enhances MMP-2 binding to TIMP-2. |
| Q40445568 | Exercise therapy augments the ischemia-induced proangiogenic state and results in sustained improvement after stroke |
| Q34730872 | Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension |
| Q50077490 | FOXO3a (Forkhead Transcription Factor O Subfamily Member 3a) Links Vascular Smooth Muscle Cell Apoptosis, Matrix Breakdown, Atherosclerosis, and Vascular Remodeling Through a Novel Pathway Involving MMP13 (Matrix Metalloproteinase 13). |
| Q33567746 | Fibulin-2 and fibulin-5 cooperatively function to form the internal elastic lamina and protect from vascular injury |
| Q33194212 | Function and structure of pressurized and perfused porcine carotid arteries: effects of in vitro balloon angioplasty |
| Q35393112 | Genetic analysis of ligation-induced neointima formation in an F2 intercross of C57BL/6 and FVB/N inbred mouse strains |
| Q36027006 | Genetic interleukin-10 deficiency causes vascular remodeling via the upregulation of Nox1. |
| Q33765867 | Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene |
| Q35763571 | HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation |
| Q33606446 | Hemodynamics and axial strain additively increase matrix remodeling and MMP-9, but not MMP-2, expression in arteries engineered by directed remodeling |
| Q50212129 | Inhibition of pro-/active MMP-2 by green tea catechins and prediction of their interaction by molecular docking studies. |
| Q28573239 | Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries |
| Q53073185 | Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation. |
| Q42860227 | Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling |
| Q37664093 | MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells |
| Q34405713 | MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9. |
| Q41949055 | Maspin impairs the function of endothelial cells: an implying pathway of preeclampsia |
| Q37983293 | Matrix metalloproteinase inhibition therapy for vascular diseases |
| Q35583908 | Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques |
| Q51786158 | Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. |
| Q41537655 | Matrix metalloproteinase-9-null mice are resistant to TGF-β-induced anterior subcapsular cataract formation |
| Q37559372 | Matrix metalloproteinases and peripheral arterial disease |
| Q27025492 | Matrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approaches |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q34946905 | Mechanical stretch increases MMP-2 production in vascular smooth muscle cells via activation of PDGFR-β/Akt signaling pathway |
| Q36583453 | Mechanical stretching stimulates collagen synthesis via down-regulating SO2/AAT1 pathway |
| Q91965556 | Mechanotransduction in the Cardiovascular System: From Developmental Origins to Homeostasis and Pathology |
| Q35107597 | Membrane type-matrix metalloproteinases (MT-MMP) |
| Q62693721 | Metaloproteasa-10 (estromelisina-2): un nuevo marcador de aterosclerosis subclínica |
| Q35158162 | P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo |
| Q43682973 | Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors |
| Q36471316 | Protein turnover during in vitro tissue engineering |
| Q34081328 | Recent advances in molecular mechanisms of abdominal aortic aneurysm formation |
| Q88478694 | Reduced embryonic blood flow impacts extracellular matrix deposition in the maturing aorta |
| Q38969474 | Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness |
| Q24672221 | Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis |
| Q28573681 | S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo |
| Q53763554 | Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. |
| Q35660086 | Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice |
| Q33371165 | Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation |
| Q47245105 | The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling |
| Q39116345 | The Susceptibility Pathogenesis of Moyamoya Disease |
| Q28360490 | The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair |
| Q33904413 | The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases |
| Q36496252 | The pathobiology of the vessel wall: implications for imaging |
| Q33805041 | The role of matrix metalloproteinases in atherothrombosis. |
| Q35111511 | Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point |
| Q33748607 | Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties |